Thus, we suggest that microbiome-induced butyrate inhibits colon cancer growth by regulating the HECTD2-EHMT2-TNFAIP1 axis and HDAC activity, as shown by SP treatment. The gene discussed is EHMT2; the disease is malignant colon neoplasm.